Certara
Serving as Certara CEO since June 2014, Dr. Edmundo Muniz has stepped down, as the company in May announced Dr. William F. Feehery as its new CEO and a member of the Certara Board of Directors.
Muniz will become a member of the Certara Board of Directors and Chair of the Board’s newly-formed Science Committee.
Feehery joins Certara from DuPont, where was president of DuPont Industrial Biosciences since 2013.
Prior to DuPont in 2002, he worked in venture capital and as a consultant for the Boston Consulting Group. He also is a board member for West Pharmaceutical Services.